ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $816,848 | -26.6% | 30,400 | -2.6% | 0.02% | -24.0% |
Q2 2023 | $1,112,592 | +52.6% | 31,200 | +8.7% | 0.02% | +38.9% |
Q1 2023 | $728,980 | +63400.0% | 28,700 | +1.4% | 0.02% | -41.9% |
Q4 2022 | $1,148 | -99.9% | 28,300 | +0.4% | 0.03% | +14.8% |
Q3 2022 | $932,000 | -21.4% | 28,200 | +1.4% | 0.03% | -15.6% |
Q2 2022 | $1,186,000 | -6.1% | 27,800 | +0.7% | 0.03% | +6.7% |
Q1 2022 | $1,263,000 | -28.9% | 27,600 | +3.0% | 0.03% | -23.1% |
Q4 2021 | $1,777,000 | +7.0% | 26,800 | +0.8% | 0.04% | -2.5% |
Q3 2021 | $1,661,000 | -25.7% | 26,600 | -1.5% | 0.04% | -25.9% |
Q2 2021 | $2,236,000 | +24.9% | 27,000 | 0.0% | 0.05% | +14.9% |
Q1 2021 | $1,790,000 | -9.2% | 27,000 | +5.1% | 0.05% | -17.5% |
Q4 2020 | $1,972,000 | +79.6% | 25,700 | +0.8% | 0.06% | +11.8% |
Q3 2020 | $1,098,000 | +0.1% | 25,500 | +0.4% | 0.05% | -21.5% |
Q2 2020 | $1,097,000 | +57.6% | 25,400 | +5.0% | 0.06% | +27.5% |
Q1 2020 | $696,000 | -54.7% | 24,200 | 0.0% | 0.05% | -32.9% |
Q4 2019 | $1,535,000 | +54.7% | 24,200 | -31.2% | 0.08% | +46.2% |
Q3 2019 | $992,000 | +3.5% | 35,200 | -0.3% | 0.05% | +8.3% |
Q2 2019 | $958,000 | – | 35,300 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |